PeerVoice Internal Medicine Audio: Recent Episodes
PeerVoice
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care
Jonathan Barratt, PhD, FRCP / Joris Roelofs, MD, PhD - The Central Role of Renal Pathology in the Differential Diagnosis of Glomerular Diseases: Sharing Expertise, Experience, and Essential Next Steps
Harry Paul Erba, MD, PhD - New Tools, New Considerations: Optimizing Our Approaches to Managing Newly Diagnosed FLT3-Mutant AML
Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED
Carla M. Nester, MD, MSA, FASN - Novel Therapies in Focus: Updates in C3 Glomerulopathy and IC-MPGN
Richard Kim, MD - The Modern Art of Sequencing Later Lines of Treatment for Advanced Colorectal Cancer: Exploring Case Scenarios With the Experts
Elena Castro, MD, PhD - Innovation and Individualisation in mHSPC and nmCRPC: Optimising Patient Outcomes and Experiences
Karin Jordan, MD, PhD - Applying Foresight to Optimise Emesis Control in Patients Receiving Antibody-Drug Conjugates
Karin Jordan, MD, PhD - Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting
Peter Schmid, FRCP, MD, PhD - Staying at the Forefront of HER2 and TROP2-Directed Antibody-Drug Conjugate Advances in Breast Cancer
Jiwon Oh, MD, PhD, FRCPC - Navigating the High-Efficacy DMT Landscape in MS: Integrating New Data and Real-World Evidence
Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey
Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding
Pamela Kushner, MD, FAAFP / Magdalena Madero, MD - Taking the Updated CKD Guidelines From Paper to Practice
Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?
Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?
Jacqueline S. Garcia, MD - Small Words, Big Differences: Best Practices in Supportive Care for Patients With AML
Brandon Blue, MD - Challenging Racial Disparities in Multiple Myeloma Treatment and Outcomes: Local Solutions to Address an Endemic Problem
Richard Kim, MD - From Trial Protocol to Routine Practice: Evaluating Real-World Evidence for Later-Line Treatments in Advanced Colorectal Cancer
Jai Radhakrishnan, MD, MS, Getting Up to Speed in IgAN: An Expert-Led Rapid-Fire Journal Club Series
Philippe Moreau, MD - Assessing Current and Potential Approaches in Multiple Myeloma: Updates From Madrid 2024
Gilles Salles, MD, PhD - Differentiating Decisions in Transplant-Ineligible Relapsed/Refractory DLBCL: What Are Our Options, and How Do We Choose Between Them?
Andrea Necchi, MD - Familiar Tools, New Uses? Assessing Novel Combination Approaches in the First-Line Management of Advanced Urothelial Carcinoma
María-Victoria Mateos, MD, PhD - Updates in Multiple Myeloma From Madrid: Data Surrounding BCMA-Directed Agents and Their Clinical Relevance
Isabel Conceição, MD - Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making
Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA
Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis
Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia
Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy
Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making
Angela Kay Fitch, MD, FACP, MFOMA - Unpacking Impressions and Perceptions of Novel Treatments for Obesity: How Would You Respond to These Questions in Primary Care?
Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?
Lindsey Roeker, MD - Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimilar Agents
Thomas Powles, MBBS, MRCP, MD - Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best Practices and Future Directions in Maintenance Therapy
Sara Hurvitz, MD - A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer
Christian Récher, MD, PhD - Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Optimising Our First-Line Approaches With Current and Novel Therapeutics
Jeffrey Szer, MBBS, FRACP - The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
Dirk Arnold, MD - Navigating Decisions With Limited Tools: A Review of Best Practices in Managing Metastatic Colorectal Cancer
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
Lisa Licitra, MD - Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy in Patients With SCCHN?
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Bertrand Tombal, MD, PhD - MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes
Javed Butler, MD, MPH, MBA - Practical Perspectives and Straightforward Strategies for Optimising GDMT in HFrEF: The Role of ARNI as a Fundamental Building Block
Nils Erik Gilhus, MD, PhD - Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Therapy in Generalised Myasthenia Gravis
Wisia Wedzicha, MD, FRCP - Taking the Evidence from Paper to Practice: Shared Perspectives on Practical Considerations in Comprehensive COPD Care
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
Amy E. DeZern, MD, MHS - Small Words Make Large Differences: Best Practices in Supporting MDS Patients Across All Stages of Their Journey
David M. G. Halpin, MB BS, DPhil, FERS - The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of Disability and Death
Ana C. Garrido-Castro, MD / Sarah L. Sammons, MD - TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct
Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can
Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
Laurent Servais, MD, PhD - Catch Them Before They Fall: A Call to Action for Comprehensive Testing for Hypotonia in Paediatric Patients
Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting
Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations
Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD
Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care
Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations
Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment
Ronald F. van Vollenhoven, MD, PhD - Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC
Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care
Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers
Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary Care
Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment
Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools
Sharon Walmsley, CM, MSc, MD - Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey
Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?
Lorenza Rimassa, MD - When One Size Doesn’t Fit All: Optimising Molecular Testing and Personalising Treatment Planning in Cholangiocarcinoma
Wong Seng Weng, MBBS, MRCP, FAMS - Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?
David Planchard, MD, PhD - Catching Up on CEACAM5 in NSCLC: The Whys and Hows of Detection and Targeting
Gilles Salles, MD, PhD - Differentiating Decisions in Transplant-Ineligible Relapsed/Refractory DLBCL: What Are Our Options, and How Do We Choose Between Them?
Antonella Castagna, MD - Designing Treatment Regimens to Suppress Multidrug-Resistant HIV: What Would You Do?
David Malka, MD, PhD - Let’s Get Personal: Effective and Individualised Management of Targeted Therapies in Cholangiocarcinoma
Jacqueline Turner, MSc - Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
Jai Radhakrishnan, MD, MS / Ladan Zand, MD - Investigating Novel Approaches and Unmet Needs in the Management of Glomerular Diseases
Melanie J. Davies, CBE, FRCP, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies
Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart Failure
Michael K. Wong, MD, PhD, FRCPC - Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?
P. James B. Dyck, MD - When ATTR Amyloidosis Strikes a Nerve: Best Practices in Timely Suspicion, Diagnosis, and Management of ATTR-Polyneuropathy
Michael Thorpy, MD - Dual Duty: Protecting Cardiovascular Health in Patients With Narcolepsy
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary Viewpoints
Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?
Aditya Bardia, MD, MPH - Keeping to Target in mTNBC: Optimising Outcomes With Antibody-Drug Conjugates in Practice
Arndt Vogel, MD - Options and Opportunities in Cholangiocarcinoma: Novel Approaches for Targeting FGFR Alterations
Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?
Verónica Vázquez Velázquez, PhD - Optimising Obesity Care in Adolescent Patients: Practical Blueprints to Overcome Barriers
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs
Kurt G. Naber, MD, PhD - How Are We Tackling the Nemesis of Drug-Resistant Uropathogens?
Allison Agwu, MD, ScM - Me the Clinician; Me the Mom: Why Vaccinate Children Against COVID-19?
Luis Alberto Moreno, MD, PhD / Aaron Kelly, PhD - Assessing and Alleviating the Weight of Obesity in Adolescent Patients
Nizar Mahlaoui, MD, MPH, PhD - Simplifying Patient-Integrated Care for Those Requiring Immunoglobulin Therapy: Making Smart Moves with Automated and Digital Technology
Kevin Harrington, PhD, FRCR, FRCP - When CPS is Between 1 and 19, How Would You Manage Recurrent/Metastatic SCCHN?
Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact Clinicians
Thomas Powles, MBBS, MRCP, MD - Education, Collaboration and Communication: Aligning Patient and Clinical Priorities in Locally Advanced and Metastatic Urothelial Carcinoma
Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management Strategies
Mary Frances McMullin, MD, FRCP, FRCPath - Managing Myelofibrosis: Can We Do More to Address Cytopenias, Reduce Transfusion Burden, and Improve Quality of Life?
Andrew Ustianowski, MBBS, FRCP, PhD - Treating COVID-19 Early: What Patients Need to Know
Arndt Vogel, MD - Mobilising the Multidisciplinary Team: Collaborative Strategies to Improve Care in Early- to Intermediate-Stage HCC
Marina Berenguer, MD, PhD - Treating Hepatitis C Virus in Special Populations: Pregnant Women, Children and Adolescents
Amitava Banerjee, MPH, DPhil, FRCP - Long COVID and Vaccination Status: What Are We Learning?
Silke Gillessen, MD - Optimal Treatment of mCRPC: What Is the Place of Radioligand Therapy?
Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients
Solange Peters, MD, PhD - Advancing Our Patient-Centered Approach to Care in ALK-Positive Metastatic Non-Small Cell Lung Cancer
Anil K. Gupta, MD, CCFP, FCFP - Treating COVID-19 in the Outpatient Setting: Identifying Who, With What, and When?
Samuel Seidu, MD, FRCGP, FRCP (Edin) - The Power of the Primary Point of Contact: Taking Obesity From Obstacle to Opportunity
Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient Outcomes
Andrew Ustianowski, MBBS, FRCP, PhD - What’s Right for Me: Individualising Antiretroviral Therapy in People Living With HIV
Eugen Feist, MD - Anwendung der ersten deutschen AOSD-Therapieleitlinien: die Rolle und Position von Biologika
David T. Rubin, MD, AGAF - What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis
Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team
Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?
Ronald van Vollenhoven, MD, PhD - Managing Patients with Lupus: When Should We Escalate Treatment?
Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections
Frederique Penault-Llorca, MD, PhD - Setting Our Sights on Actionable Mutations in Cholangiocarcinoma: The Who, What, When, Why, and How of Testing
Bruno Sangro, MD, PhD - A New Era in the Management of Advanced HCC: Sequencing Therapies for the Second-Line and Beyond
Perry Elliott, MD, FRCP, FESC - Thickening of the Heart, and HCM Is to Blame: A Call for Improved Recognition, Diagnosis, and Management of HCM
Michael H. Hsieh, MD, PhD, FASTMH - Differentiating UTIs From STIs in Primary Care: Cases in Practice
Susana Banerjee, MBBS, MA, PhD - When Patients With Advanced Endometrial Cancer Progress: Decisions in Treatment Initiation and Optimisation
Isabelle Ray-Coquard, MD, PhD - Turning Advanced Ovarian Cancer Into a Chronic Disease One Step at a Time
Shimu Khamlichi, BSc, ClinPsyD - Protecting the Mental Health of People Living With HIV
Jonathan Barratt, PhD, FRCP - In Pursuit of Proteinuria: Novel Therapeutic Approaches in the Management of IgAN
Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs
Egbert F. Smit, MD, PhD - Novel Antigenic Targets for Antibody-Drug Conjugates in NSCLC
Graeme C Black, OBE, DPhil, FRCOphth, FMedSci - Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
Anil K. Gupta, MD, CCFP, FCFP / Nathan Peiffer-Smadja, MD, PhD - Steps Towards Preventing COVID-19 Variants: Because Every Individual Counts
Donna Ryan, MD, FTOS, MABOM - Practical Makes Perfect: Pragmatic Guidance for Implementation of GLP-1 RAs Across the Trajectory of T2D
Melanie J. Davies, CBE, FRCP, FMedSci - Clinical Challenges in Insulin Initiation: Overcoming Obstacles to Improved Glycaemic Control in Type 2 Diabetes
Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency
Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression
Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian Syndrome
José R. Arribas, MD - Mastering the Management of Multidrug-Resistant HIV: When, With What, and How
"Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians "
Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat
Noemi Reguart, MD, PhD - Evaluating the Evidence for Emerging Therapies in NSCLC: Highlights From Summer/Fall 2022
Javed Butler, MD, MPH, MBA - Changing the Patient Journey Across the Spectrum of Heart Failure
Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals
Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC
Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?
Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions
Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care
Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias
Advanced Therapy for CPF in Crohn's: Evaluating the Evidence for Stem Cell Therapy and More
Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC
Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022
Perspectives on the Management of CPF: Moving the Goalposts With Shared Decision-Making
The Fear of Disappearing, the Fight to Stay Present': Understanding the Needs of Patients With Alzheimer's Disease
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale is Compromised
A Clinical Conversation on Metastatic Hormone-Sensitive Prostate Cancer: Intensifying Therapy Earlier in the Disease Course
"Incorporating Immunotherapy in Advanced and Recurrent Endometrial Cancer: Applying Knowledge to Practice"
Help, I Have COVID': Primary Care Support and Therapeutic Management of Patients With Mild/Moderate COVID-19
When the Immune System Attacks: The Impact, Pathophysiology, and Treatment of Alopecia Areata
JAK Inhibitors in the Management of Dermatologic Disorders: Clinical Implications of the Latest Safety Findings
Shining a Light on the Treatment of Primary Hyperoxaluria 1: Does the Evidence Improve Our Options?
Individualising Enzyme Replacement Therapy in Patients Living with Late-Onset Pompe Disease
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
Applying Revised Treatment Guidelines for Advanced Hepatocellular Carcinoma: Considerations in Real-Life Practice
The Place of Radiopharmaceuticals in an Evolving Treatment Landscape: Addressing Perceptions With Clinical Evidence to Optimise Outcomes in Men With Metastatic Prostate Cancer
"Anil K. Gupta, MD, CCFP, FCFP - Preventing COVID Progression and Transmission in the Outpatient Setting: Keeping Abreast of Therapeutic Developments"
"Jacob Pontoppidan Thyssen, MD, PhD, DmSci - A Clinical Round-Up on the Impact of COVID-19 in Patients With Atopic Dermatitis: Management; Outcomes; Vaccination"
Aktuelles zur Behandlung der IgA-Nephropathie: Welche Neuerungen gibt es und was bedeuten sie für die Patienten?
Ensuring Long-Term Success in Advanced Ovarian Cancer: Sequencing Therapy Based on Science
Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale Is Compromised
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses
Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them
The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care
A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes
An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?
Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies
Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action
Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!
Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses
Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?
Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
"Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?"
Simplifying Screening for Immunodeficiencies: A Practical Strategy Using Calculated Serum Globulin
Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold
Checking In on Checkpoint Inhibitors: Current and Emerging Strategies for High PD-L1–Expressing Tumours in Advanced NSCLC
Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data
Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer
Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists
If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis
Optimising Standard of Care for Patients With Axial Spondyloarthropathies: Why Gender Matters!
Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes
Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Beyond HPIs for Advanced Basal Cell Carcinoma: Exploring the Clinical Implications of New Evidence
Breaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike
Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data
Extending Overall Survival in Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) While Maintaining Quality of Life: Can We Have it All?
Unmet Needs in Familial Mediterranean Fever (FMF): Real-Life Data, the Patient Perspective, and the Role of Anti–IL-1 Therapy
Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist
Are All Biologics the Same? Optimal Treatment Strategies for Patients With Inflammatory Bowel Disease
Extending Your Interdisciplinary Understanding of IL-6R Inhibitors in Rheumatoid Arthritis
Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?
Weighing Evidence and Perspectives on JAK Inhibitors in Psoriatic Arthritis: Can We Do More for Patients?
"Optimising the Use of JAK Inhibitors in RA: Translating the Latest Evidence Into Today’s Clinical Practice"
Early Disease Control in Inflammatory Bowel Disease: Integrating the Latest Evidence for Better Outcomes
Defining a Patient-Centred Approach to Non-Metastatic Castration-Resistant Prostate Cancer
Wake Up and Smell the Coffee: Kicking Into Play Novel Treatment Options for Nasal Polyposis
Practical Lessons From Real-World Evidence on CDK 4/6 Inhibitors in Metastatic Breast Cancer
Changing Strategies for Changing Times: Optimising Use of Targeted Alpha Therapies for Advanced Prostate Cancer
Raising the Caliber of Non-Metastatic CRPC Care: Introducing Quality of Life Into the Equation
Individualising Stroke Prevention in Older Adults With Atrial Fibrillation (How I Treat)
Going Deep With Complex Perianal Fistulas in Crohn’s Disease: Analysing the Evidence for Stem-Cell Therapy
Building on the Pillars of IBD Treatment: Early Intervention, Treat-to-Target, and Tight Control
Individualising HIV Care to Optimise Outcomes: Clinical Points of View and Practical Considerations for Switching ART
Evolving the Treatment Paradigm in HER2-Positive Breast Cancer: Are New Options on the Horizon?
A Topical Approach to Mild-to-Moderate Atopic Dermatitis: Finding the Right Fit for Patients of All Ages
The Evolving Landscape in Advanced CTCL: Can Emerging Therapies Enhance Patient Management?
Staying Ahead of Perianal Fistulas in Crohn's Disease: A Focused Approach to Management
"Managing Stroke Risk Due to Atrial Fibrillation in Older Patients: Expert Perspectives"
Evolution of Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Approaches to Management
Immuno-oncology for mRCC: Considerations for a Combination Approach in the First-Line Setting
Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment
Making Heads and Tails of CGRP-Targeting Therapies: How Will They Fit Into Migraine Prevention Strategies?
Understanding Hypercapnia in Acute Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes
Maximising the Long-Term Treatment Plan for Unresectable Hepatocellular Carcinoma: A Sequential Approach to Improving Patient Outcomes
The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma
Meeting the Clinical Challenge: Individualising Anticoagulation for Patients With AF and ACS
Optimising the Treatment of mRCC From the Start: Evaluating the Impact of Evolving First-Line Strategies
Teaming Up to Improve Outcomes in Immunology: The Importance of an Integrated Approach to Disease Control
Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy
Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions
Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer
Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression
Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer
Spotlight on Disease Burden and Quality of Life in Atopic Dermatitis: Are We Missing the Big Picture?
A High Index of Suspicion: The Key to Early Diagnosis and Treatment of Atypical Haemolytic Uraemic Syndrome
Wheeze, Asthma, and Lung Function: Latest Insights on the Long-Term Impact of Severe RSV in Infancy
Management of Autoinflammatory Recurrent Fever Syndromes: What Recent Data Results Mean for Clinical Practice
Developing a Selective Approach to Prevent Pain Crisis in Sickle Cell Disease: Can Emerging Therapies Pave the Way?
Expert Perspectives: Weighing the Evidence for Current and Emerging Therapies in the Management of Advanced Renal Cell Carcinoma
Double Trouble: The Impact of Viral and Bacterial Coinfection in Children With RSV-CAAP and What to Do About It
Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey
Targeting IL1-β Toward Remission in Auto-Inflammatory Diseases – Expert Perspectives on Recent Clinical Data
Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes
Spotlight on Adult ADHD and Substance Use Disorder: Identifying and Managing Difficult Cases
Conversations on Steps to Biologic Therapy for Atopic Dermatitis: Patient and Dermatologist Insights for European Practice
Exploring Treatment Choices in Crohn’s Disease: Using Current Evidence to Optimize Outcomes
Modern Management of Patients With Rheumatic Diseases: What Pharmacists Need to Know About Biologic Therapies
An Integrative Approach to the Management of Spondyloarthritis: Improving Clinical Outcomes and Quality of Life
Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer
Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco
Protecting Adolescents and Adults From Vaccine Preventable Bacterial Diseases: A Look at Serogroup B Meningococcal Disease and Pneumococcal Diseases
Treating Rheumatoid Arthritis and Spondyloarthritis to Target: What Are We Missing in Clinical Practice?
Looking Beyond the Skin and Joints in Psoriatic Arthritis: A Comprehensive Approach to Improving Patient Outcomes
New Strategies, New Targets: The Evolving Landscape in Driver-Mutation–Positive Advanced NSCLC
Von der Krankheitsentstehung zu klinischen Strategien für autoinflammatorische und Autoimmunerkrankungen: Welche Rolle spielen Interleukine?
Enthesitis in Psoriatic Arthritis and Spondyloarthritis: Targeting Pathophysiologic Mechanisms to Optimise Patient Management
Addressing the Management Challenges of JIA-Associated Uveitis: From Screening to Treatment